Antibiotic susceptibility of aggregatibacter actinomycetemcomitans JP2 in a biofilm

Journal of Oral Microbiology

Volumn 5, Issue 2013, 2013, Pages

  Oettinger Barak, Orit ^a   Dashper, Stuart G ^a   Catmull, Deanne V ^a   Adams, Geoffrey G ^a   Sela, Michael N ^b   Machtei, Eli E ^c,d   Reynolds, Eric C ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c Endodontics and Dental Trauma Unit   (Israel)

^d Harvard Medical Center   (United States)

Author keywords

Aggregatibacter actinomycetemcomitans; Biofilm; Doxycycline; Localized aggressive periodontitis; Metronidazole

Indexed keywords

AMOXICILLIN; DOXYCYCLINE; METRONIDAZOLE;

AGGREGATIBACTER ACTINOMYCETEMCOMITANS; AGGRESSIVE PERIODONTITIS; ANALYTICAL PARAMETERS; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BIOFILM; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; IN VITRO STUDY; LOCALIZED AGGRESSIVE PERIODONTITIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PLANKTON; THICKNESS;

EID: 84879317325     PISSN: None     EISSN: 20002297     Source Type: Journal    
DOI: 10.3402/jom.v5i0.20320     Document Type: Article

References (61)

1. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999; 4: 1-6.
2. Faveri M, Figueiredo LC, Duarte PM, Mestnik MJ, Mayer MP, Feres M. Microbiological profile of untreated subjects with localized aggressive periodontitis. J Clin Periodontol 2009; 36: 739-49.
3. Wang CY, Wang HC, Li JM, Wang JY, Yang KC, Ho YK, et al. Invasive infections of Aggregatibacter (Actinobacillus) actinomycetemcomitans. J Microbiol Immunol Infect 2010; 43: 491-7.
4. Stepanovic S, Tosic T, Savic B, Jovanovic M, K'Ouas G, Carlier JP. Brain abscess due to Actinobacillus actinomycetemcomitans. APMIS 2005; 113: 225-8.
5. Barak S, Oettinger-Barak O, Machtei EE, Sprecher H, Ohel G. Evidence of periopathogenic microorganisms in placentas of women with preeclampsia. J Periodontol 2007; 78: 670-6.
6. Slots J. Systemic antibiotics in periodontics. J Periodontol 2004; 75: 1553-65.
7. Mandell RL, Tripodi LS, Savitt E, Goodson JM, Socransky SS. The effect of treatment on Actinobacillus actinomycetemcomitans in localized juvenile periodontitis. J Periodontol 1986; 57: 94-9.
8. Akincibay H, Orsal SO, Sengun D, Tozum TF. Systemic administration of doxycycline versus metronidazole plus amoxicillin in the treatment of localized aggressive periodontitis: a clinical and microbiologic study. Quintessence Int 2008; 39: e33-9.
9. van Winkelhoff AJ, Rodenburg JP, Goene RJ, Abbas F, Winkel EG, de Graaff J. Metronidazole plus amoxycillin in the treatment of Actinobacillus actinomycetemcomitans associated periodontitis. J Clin Periodontol 1989; 16: 128-31.
10. Rooney J, Wade WG, Sprague SV, Newcombe RG, Addy M. Adjunctive effects to non-surgical periodontal therapy of systemic metronidazole and amoxycillin alone and combined. A placebo controlled study. J Clin Periodontol 2002; 29: 342-50.
11. Winkel EG, Van Winkelhoff AJ, Timmerman MF, Van der Velden U, Van der Weijden GA. Amoxicillin plus metronidazole in the treatment of adult periodontitis patients. A doubleblind placebo-controlled study. J Clin Periodontol 2001; 28: 296-305.
12. Sigusch B, Beier M, Klinger G, Pfister W, Glockmann E. A 2-step non-surgical procedure and systemic antibiotics in the treatment of rapidly progressive periodontitis. J Periodontol 2001; 72: 275-83.
13. Kunihira DM, Caine FA, Palcanis KG, Best AM, Ranney RR. A clinical trial of phenoxymethyl penicillin for adjunctive treatment of juvenile periodontitis. J Periodontol 1985; 56: 352-8.
14. Saxen L, Asikainen S. Metronidazole in the treatment of localized juvenile periodontitis. J Clin Periodontol 1993; 20: 166-71.
15. Noyan U, Yilmaz S, Kuru B, Kadir T, Acar O, Buget E. A clinical and microbiological evaluation of systemic and local metronidazole delivery in adult periodontitis patients. J Clin Periodontol 1997; 24: 158-65.
16. Fine DH, Furgang D, Kaplan J, Charlesworth J, Figurski DH. Tenacious adhesion of Actinobacillus actinomycetemcomitans strain CU1000 to salivary-coated hydroxyapatite. Arch Oral Biol 1999; 44: 1063-76.
17. Cvitkovitch DG, Li YH, Ellen RP. Quorum sensing and biofilm formation in Streptococcal infections. J Clin Invest 2003; 112: 1626-32.
18. Larsen T. Susceptibility of Porphyromonas gingivalis in biofilms to amoxicillin, doxycycline and metronidazole. Oral Microbiol Immunol 2002; 17: 267-71.
19. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science 1999; 284: 1318-22.
20. Fine DH, Furgang D, Barnett ML. Comparative antimicrobial activities of antiseptic mouthrinses against isogenic planktonic and biofilm forms of Actinobacillus actinomycetemcomitans. J Clin Periodontol 2001; 28: 697-700.
21. Shapiro S, Giertsen E, Guggenheim B. An in vitro oral biofilm model for comparing the efficacy of antimicrobial mouthrinses. Caries Res 2002; 36: 93-100.
22. Dashper S, Ang CS, Liu SW, Paolini R, Veith P, Reynolds E. Inhibition of Porphyromonas gingivalis biofilm by oxantel. Antimicrob Agents Chemother 2010; 54: 1311-4.
23. Izano EA, Wang H, Ragunath C, Ramasubbu N, Kaplan JB. Detachment and killing of Aggregatibacter actinomycetemcomitans biofilms by dispersin B and SDS. J Dent Res 2007; 86: 618-22.
24. Takayama S, Saitoh E, Kimizuka R, Yamada S, Kato T. Effect of eel galectin AJL-1 on periodontopathic bacterial biofilm formation and their lipopolysaccharide-mediated inflammatory cytokine induction. Int J Antimicrob Agents 2009; 34: 355-9.
25. Slots J. Selective medium for isolation of Actinobacillus actinomycetemcomitans. J Clin Microbiol 1982; 15: 606-9.
26. Draper NR, Smith H. Applied regression analysis. New York: Wiley; 1981. p. 1-55.
27. Heydorn A, Nielsen AT, Hentzer M, Sternberg C, Givskov M, Ersboll BK, et al. Quantification of biofilm structures by the novel computer program COMSTAT. Microbiology 2000; 146: 2395-407.
28. Pascale D, Gordon J, Lamster I, Mann P, Seiger M, Arndt W. Concentration of doxycycline in human gingival fluid. J Clin Periodontol 1986; 13: 841-4.
29. Kim TS, Frank P, Eickholz P, Eick S, Kim CK. Serotypes of Aggregatibacter actinomycetemcomitans in patients with different ethnic backgrounds. J Periodontol 2009; 80: 2020-7.
30. Tinoco EM, Sivakumar M, Preus HR. The distribution and transmission of Actinobacillus actinomycetemcomitans in families with localized juvenile periodontitis. J Clin Periodontol 1998; 25: 99-105.
31. Brogan JM, Lally ET, Poulsen K, Kilian M, Demuth DR. Regulation of Actinobacillus actinomycetemcomitans leukotoxin expression: analysis of the promoter regions of leukotoxic and minimally leukotoxic strains. Infect Immun 1994; 62: 501-8.
32. Haubek D, Dirienzo JM, Tinoco EM, Westergaard J, Lopez NJ, Chung CP, et al. Racial tropism of a highly toxic clone of Actinobacillus actinomycetemcomitans associated with juvenile periodontitis. J Clin Microbiol 1997; 35: 3037-42.
33. Haubek D, Poulsen K, Kilian M. Microevolution and patterns of dissemination of the JP2 clone of Aggregatibacter (Actinobacillus) actinomycetemcomitans. Infect Immun 2007; 75: 3080-8.
34. Haubek D, Ennibi OK, Poulsen K, Vaeth M, Poulsen S, Kilian M. Risk of aggressive periodontitis in adolescent carriers of the JP2 clone of Aggregatibacter (Actinobacillus) actinomycetemcomitans in Morocco: a prospective longitudinal cohort study. Lancet 2008; 371: 237-42.
35. Cortelli SC, Costa FO, Kawai T, Aquino DR, Franco GC, Ohara K, et al. Diminished treatment response of periodontally diseased patients infected with the JP2 clone of Aggregatibacter (Actinobacillus) actinomycetemcomitans. J Clin Microbiol 2009; 47: 2018-25.
36. Rylev M, Bek-Thomsen M, Reinholdt J, Ennibi OK, Kilian M. Microbiological and immunological characteristics of young Moroccan patients with aggressive periodontitis with and without detectable Aggregatibacter actinomycetemcomitans JP2 infection. Mol Oral Microbiol 2011; 26: 35-51.
37. Rylev M, Kilian M. Prevalence and distribution of principal periodontal pathogens worldwide. J Clin Periodontol 2008; 35: 346-61.
38. Eick S, Pfister W. Efficacy of antibiotics against periodontopathogenic bacteria within epithelial cells: an in vitro study. J Periodontol 2004; 75: 1327-34.
39. Pajukanta R, Asikainen S, Saarela M, Alaluusua S, Jousimies-Somer H. In vitro antimicrobial susceptibility of different serotypes of Actinobacillus actinomycetemcomitans. Scand J Dent Res 1993; 101: 299-303.
40. Stoller NH, Johnson LR, Trapnell S, Harrold CQ, Garrett S. The pharmacokinetic profile of a biodegradable controlledrelease delivery system containing doxycycline compared to systemically delivered doxycycline in gingival crevicular fluid, saliva, and serum. J Periodontol 1998; 69: 1085-91.
41. Lavda M, Clausnitzer CE, Walters JD. Distribution of systemic ciprofloxacin and doxycycline to gingiva and gingival crevicular fluid. J Periodontol 2004; 75: 1663-7.
42. Machtei EE, Younis MN. The use of 2 antibiotic regimens in aggressive periodontitis: comparison of changes in clinical parameters and gingival crevicular fluid biomarkers. Quintessence Int 2008; 39: 811-9.
43. Christersson LA, Zambon JJ. Suppression of subgingival Actinobacillus actinomycetemcomitans in localized juvenile periodontitis by systemic tetracycline. J Clin Periodontol 1993; 20: 395-401.
44. Haffajee AD, Dibart S, Kent RL, Socransky SS Jr. Clinical and microbiological changes associated with the use of 4 adjunctive systemically administered agents in the treatment of periodontal infections. J Clin Periodontol 1995; 22: 618-27.
45. Walker CB, Godowski KC, Borden L, Lennon J, Nango S, Stone C, et al. The effects of sustained release doxycycline on the anaerobic flora and antibiotic-resistant patterns in subgingival plaque and saliva. J Periodontol 2000; 71: 768-74.
46. Asikainen S, Jousimies-Somer H, Kanervo A, Saxen L. The immediate efficacy of adjunctive doxycycline in treatment of localized juvenile periodontitis. Arch Oral Biol 1990; 35(Suppl): 231S-4.
47. Mombelli A, Tonetti M, Lehmann B, Lang NP. Topographic distribution of black-pigmenting anaerobes before and after periodontal treatment by local delivery of tetracycline. J Clin Periodontol 1996; 23: 906-13.
48. Feres M, Haffajee AD, Goncalves C, Allard KA, Som S, Smith C, et al. Systemic doxycycline administration in the treatment of periodontal infections (I). Effect on the subgingival microbiota. J Clin Periodontol 1999; 26: 775-83.
49. Wong MY, Lu CL, Liu CM, Hou LT. Microbiological response of localized sites with recurrent periodontitis in maintenance patients treated with tetracycline fibers. J Periodontol 1999; 70: 861-8.
50. Walker CB. The acquisition of antibiotic resistance in the periodontal microflora. Periodontol 2000 1996; 10: 79-88.
51. van Winkelhoff AJ, Winkel EG, Barendregt D, Dellemijn- Kippuw N, Stijne A, van der Velden U. beta-Lactamase producing bacteria in adult periodontitis. J Clin Periodontol 1997; 24: 538-43.
52. Rodrigues RM, Goncalves C, Souto R, Feres-Filho EJ, Uzeda M, Colombo AP. Antibiotic resistance profile of the subgingival microbiota following systemic or local tetracycline therapy. J Clin Periodontol 2004; 31: 420-7.
53. van Winkelhoff AJ, Tijhof CJ, de Graaff J. Microbiological and clinical results of metronidazole plus amoxicillin therapy in Actinobacillus actinomycetemcomitans-associated periodontitis. J Periodontol 1992; 63: 52-7.
54. Walker C, Karpinia K. Rationale for use of antibiotics in periodontics. J Periodontol 2002; 73: 1188-96.
55. Pavicic MJ, van Winkelhoff AJ, Pavicic-Temming YA, de Graaff J. Amoxycillin causes an enhanced uptake of metronidazole in Actinobacillus actinomycetemcomitans: a mechanism of synergy. J Antimicrob Chemother 1994; 34: 1047-50.
56. Ardila CM, Lopez MA, Guzman IC. High resistance against clindamycin, metronidazole and amoxicillin in Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans isolates of periodontal disease. Med Oral Patol Oral Cir Bucal 2010; 15: e947-51.
57. Larsen T, Fiehn NE. Development of a flow method for susceptibility testing of oral biofilms in vitro. APMIS 1995; 103: 339-44.
58. Cummins D, Creeth JE. Delivery of antiplaque agents from dentifrices, gels, and mouthwashes. J Dent Res 1992; 71: 1439-49.
59. Takahashi N, Ishihara K, Kato T, Okuda K. Susceptibility of Actinobacillus actinomycetemcomitans to six antibiotics decreases as biofilm matures. J Antimicrob Chemother 2007; 59: 59-65.
60. Cargill JS, Upton M. Low concentrations of vancomycin stimulate biofilm formation in some clinical isolates of Staphylococcus epidermidis. J Clin Pathol 2009; 62: 1112-6.
61. Rachid S, Ohlsen K, Witte W, Hacker J, Ziebuhr W. Effect of subinhibitory antibiotic concentrations on polysaccharide intercellular adhesin expression in biofilm-forming Staphylococcus epidermidis. Antimicrob Agents Chemother 2000; 44: 3357-63.